News about

ALS drug by Biogen and Ionis Pharmaceuticals fails in trials

Biogen and Ionis Pharmaceuticals were hoping to be the first to find a cure for ALS. That dream has now fizzled out with the companies calling it quits after receiving disappointing results from a phase 1 clinical trial.

| 27/04/2022 | By |  734

Covid vaccines for kids approved by DCGI

Covid vaccines for children above five years of age has been approved by the DCGI. The approval has been given to Covaxin, ZyCov-D, and Corbevax.

| 27/04/2022 | By |  1036

Tech-enabled capsules launched by Wellbeing Nutrition

SLOW Technology enabled capsules ensure the timely assimilation of vitamins and nutrients by the human body

| 26/04/2022 | By |  981

Zydus under three observations from FDA

Indian-based pharma company Zydus Lifesciences just got hit with a triple whammy by the U.S. FDA.

| 26/04/2022 | By |  727

Anti-Tigit drug of Roche fails stage study

Roche's Genentech had disappointing news to share this week regarding its lung cancer hopeful.

| 26/04/2022 | By |  835

Jharkhand to have a Ayush DTL

Jharkhand govt asks Ayush Ministry to set up one Ayush DTL in the state; offers land and building

| 25/04/2022 | By |  321

WHO keeps a hold on Bharat Covid vaccine

FDA slaps another hold on Ocugen, Bharat's COVID vaccine after WHO flags manufacturing problems

| 25/04/2022 | By |  804

Positive nod from FDA for Gilead's Maryland site

Gilead targets 400 jobs, assembles cell therapy manufacturing troika with FDA nod for Maryland site.

| 23/04/2022 | By |  1064

Rs. 9,000 crore promises to be invested at GAIIS

Companies in major Ayush categories pledge to invest more than Rs. 9,000 crore at GAIIS

| 23/04/2022 | By |  848

Funds of $130m raised for B cell medications

Be Bio raises $130m to foster designed B cell medications. As a feature of the financing, ARCH Venture Partners overseeing chief Steven Gillis will join Be Bio's governing body.

| 23/04/2022 | By |  730